SG1408 is an innovative bi-specific antibody therapeutic biological candidate developed by CNBG-Sumgen. It has received
Copyright Rm. 301, F3, Building C, Block 2, No. 688, Bin'an Road, Changhe Zhejiang ICP Filing No. 18039044
